← Back to catalogue

BinaxNOW RSV

FDA UDI

Class I (US FDA UDI)

by Alere Scarborough, Inc.

Identity

Trade Name
BinaxNOW RSV FDA UDI
Generic Name
Respiratory syncytial virus (RSV) antigen IVD, kit, rapid ICT, clinical FDA UDI
Device Name
A rapid test for the qualitative detection of respiratory syncytial virus (RSV) in nasal wash and nasopharyngeal swab specimens. FDA UDI
Model / Reference
430-022 FDA UDI
Description
A rapid test for the qualitative detection of respiratory syncytial virus (RSV) in nasal wash and nasopharyngeal swab specimens. FDA UDI

Identifiers

Primary DI / UDI-DI
10811877011177 FDA UDI
510(k) Number
K032166 FDA UDI
FDA Product Code
GQG FDA UDI
GMDN Term
Respiratory syncytial virus (RSV) antigen IVD, kit, rapid ICT, clinical FDA UDI

Classification

Device Class
Class I FDA UDI
Regulation Number
866.3480 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Respiratory syncytial virus (RSV) antigen IVD, kit, rapid ICT, clinical

BinaxNOW RSV by Alere Scarborough, Inc. — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Respiratory syncytial virus (RSV) antigen IVD, kit, rapid ICT, clinical.

Cleared under the same submission

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI 4b3d0f1e-e625-4ddd-b981-dd60b5904ed2 34 fields · synced May 30, 2026